Contemporary Issues in Lung CancerJones & Bartlett Publishers, 2009 M02 12 - 364 pages In the United States, lung cancer is the second most commonly diagnosed cancer and the leading cause of cancer death. Even more devastating is its five-year survival rate of only 15.8%. Despite these dismal facts, lung cancer receives little national attention and research and funding for lung cancer lags behind other cancers. The intent of Contemporary Issues in Lung Cancer: A Nursing Perspective Second Edition is to provide oncology nurses and healthcare professionals with in-depth information on the issues that surround this disease, so that they might impact both education and research and provide better care for their patients. |
From inside the book
Results 1-5 of 79
Page v
... Giselle J. Moore-Higgs Kenneth R. Olivier Part Three Special Issues Facing Individuals with Lung Cancer . . .117 7 Surviving Fatigue 119 Karin Olson 8 End-of-Life Care 131 Deborah Lowe Volker Doris Dickerson Coward v Contents.
... Giselle J. Moore-Higgs Kenneth R. Olivier Part Three Special Issues Facing Individuals with Lung Cancer . . .117 7 Surviving Fatigue 119 Karin Olson 8 End-of-Life Care 131 Deborah Lowe Volker Doris Dickerson Coward v Contents.
Page vi
... Individuals with Lung Cancer . .231 12 Living with Hope: Lung Cancer 233 Katherine Katen Moore 13 Meaning of Illness in Cancer 245 Pamela M. Calarese Part Five Assistance and Resources for Individuals Facing Lung Cancer ...
... Individuals with Lung Cancer . .231 12 Living with Hope: Lung Cancer 233 Katherine Katen Moore 13 Meaning of Illness in Cancer 245 Pamela M. Calarese Part Five Assistance and Resources for Individuals Facing Lung Cancer ...
Page ix
... individuals and families who are facing this disease. A new chapter describes how navigators play an integral part of the oncology team. Finally, Part Six exposes the reality of the untold story, the unaddressed issues, and the ...
... individuals and families who are facing this disease. A new chapter describes how navigators play an integral part of the oncology team. Finally, Part Six exposes the reality of the untold story, the unaddressed issues, and the ...
Page 3
... individuals. It is our duty as health professionals to stimulate more interest in researchers and the community at large. As healthcare professionals we should advocate for more funding to eradicate this disease. This first chapter will ...
... individuals. It is our duty as health professionals to stimulate more interest in researchers and the community at large. As healthcare professionals we should advocate for more funding to eradicate this disease. This first chapter will ...
Page 6
... Individuals Relative Survivor Rate (measurement of survival among cancer patients in comparison to the general population) 5-Year Survival Rate Overall 15.2% Caucasian males 13.4% Caucasian females 17.9% African American males 10.4 ...
... Individuals Relative Survivor Rate (measurement of survival among cancer patients in comparison to the general population) 5-Year Survival Rate Overall 15.2% Caucasian males 13.4% Caucasian females 17.9% African American males 10.4 ...
Contents
Oncology Treatment Modalities | 45 |
Special Issues Facing Individuals with Lung Cancer | 117 |
Psychosocial Issues of Individuals with Lung Cancer | 231 |
Assistance and Resources for Individuals Facing Lung Cancer | 255 |
Media and Future Research Directions | 301 |
Index | 353 |
Other editions - View all
Common terms and phrases
adjuvant agents aprepitant associated bevacizumab breathing breathlessness Bruera carboplatin carcinoma cell lung cancer chemotherapy chronic cisplatin Clinical Oncology clinical trials combination diagnosis disease docetaxel dose drug dyspnea EGFR erlotinib etoposide evaluation evidence-based factors fatigue gefitinib gemcitabine gene improve increased individuals indoor radon Internet intervention irinotecan Journal of Clinical lung cancer patients Medicine ment metastatic months NCCN nicotine non-small cell lung NSCLC Nursing Forum Oncology Nursing Oncology Nursing Forum paclitaxel palliative palliative care patient navigation patients and families patients with lung pemetrexed phase postoperative potential pulmonary quit smoking radiation therapy radiotherapy radon randomized receptors regimen reported resection respiratory response rate risk role SCLC score screening Sekido side effects small cell lung smoking cessation stage strategies support group surgical survival rate Symptom Management Table tients tion tobacco topotecan toxicity treat treatment tumor versus vinorelbine weight loss